Ibuprofen Kabi

Ibuprofen, the active ingredient in Ibuprofen Kabi, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an intravenous solution for IV use. It is employed to manage mild to moderate pain, fever, inflammation, post‑operative discomfort and musculoskeletal pain in adult patients. GNH USA supplies Ibuprofen Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ibuprofen Kabi acts systemically to reduce pain, fever and inflammation through cyclo‑oxygenase inhibition. - Mild to moderate pain: provides analgesic relief for acute and postoperative pain. - Fever: lowers elevated body temperature in febrile conditions. - Inflammation: diminishes swelling associated with musculoskeletal disorders. - Post‑operative pain: controls discomfort after surgical procedures. - Musculoskeletal pain: eases pain from strains, sprains and arthritis flares.

Adverse reactions may occur with any NSAID therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection site reactions: erythema, swelling or pain. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Severe gastrointestinal bleeding or ulceration. - Acute kidney injury or worsening of chronic renal disease. - Anaphylaxis or severe hypersensitivity reactions. - Cardiovascular events such as myocardial infarction or stroke, particularly with high‑dose or prolonged use. - Hepatotoxicity with marked elevation of transaminases.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Renal impairment: assess kidney function and adjust use if necessary. - Hepatic disease: avoid in severe liver dysfunction or monitor liver enzymes. - Cardiovascular risk: use cautiously in patients with hypertension, heart failure or prior thrombotic events. - Bleeding tendency: avoid in active peptic ulcer disease or coagulopathy. - Pregnancy and lactation: consult obstetric guidance; safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofen Kabi may alter the efficacy or safety of several concomitant medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal perfusion and precipitate kidney injury.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced antihypertensive effect and renal impairment. - Lithium: NSAIDs can increase lithium serum concentrations. - Methotrexate: decreased clearance leading to toxicity.